Source for all information: Artemis as at 31 March 2026, unless otherwise stated.
The fund is actively managed. It aims to increase the value of shareholders’ investments through a combination of income and capital growth.
Artemis Funds (Lux) – Global High Yield Bond changed its name to Artemis Funds (Lux) – Global High Yield Opportunities on 28 April 2026, reflecting three changes to its investment policy. It now has the flexibility to: increase net exposure beyond 100%; express relative single-name views in a long/short bucket; and use credit options and credit total return swaps to express investment views.
Unsurprisingly, the war in Iran had the biggest influence on high-yield markets over the quarter. The fund fell 1.3% during the three-month period compared with losses of 0.6% from its ICE BofA Merrill Lynch Global High Yield Constrained USD Hedged index benchmark and 0.9% from its peer group.
The main cause of our underperformance was our greater weighting to European credit, which lagged behind the market as investors worried about a rerun of 2022. While we have some sympathy with this view – the US’s position as a net energy exporter gives it a significant advantage at present – we think it lacks nuance, just as it did in 2022.
There are two reasons for our position. First, European cyclicals have been pinning their hopes on the German fiscal bill which, while approved last summer, has yet to result in a major increase in spending. Fortunately, there were signs the money was finally beginning to flow before the Iran conflict. The incentive to go ahead is now stronger, given growth concerns in Europe.
Second, the companies in the European high-yield market are now – by definition – companies that have survived the pressures and shortages of 2022. They have been stress-tested and found to be resilient.
| Three months | Six months | One year | Three years | Five years | |
|---|---|---|---|---|---|
| Artemis Funds (Lux) – Global High Yield Opportunities | -1.3% | 0.2% | 5.8% | 29.7% | 23.5% |
| ICE BofA Merrill Lynch Global High Yield Constrained USD Hedged index | -0.6% | 0.7% | 6.5% | 28.8% | 20.6% |
| Global High Yield Bond average | -0.9% | 0.4% | 6.0% | 25.4% | 19.3% |
Past performance is not a guide for the future. Source: Lipper Limited to 31 March 2026 for class I Acc USD. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor’s currency is different to that of the class.
We had some weakness in some of our software-related names, including ZipRecruiter and games publisher Ubisoft, due to fears about the threat posed by AI.
For ZipRecruiter, we feel the concerns overlook the durability provided by network effects.
When it comes to Ubisoft, we see AI as being an unambiguous positive. Ubisoft’s ‘moat’ is its creative intellectual property (through titles such as Assassin’s Creed, Far Cry and Rainbow Six) and accompanying fanbases and communities. The company has been open about its use of AI in the past and the role it can play in reducing development costs and enhancing in-game play.
Synthomer was pressured by concerns around potential refinancing risk. There were rumours it would sell one of its divisions to help solve its balance sheet issue, a move we doubted would turn out as hoped. We halved the position size in February, then when the volatility of March made a sale less likely, we sold the position.
Elsewhere, bonds in telecommunications company Arqiva fell on rising concerns around UK TV distribution policy.
Accendra Health lagged due to worries around its business model, but we believe delivery against operating targets over the year will help re-anchor market perceptions.
Our oil & gas holdings (including BlueNord and W&T Offshore) did well as crude prices rallied through March.
Other positive contributors included French fashion house Isabel Marant on a proposed modification to the bond terms, and SNF, the French chemicals company, on an early call as part of a refinancing.
Commodity chemicals company Ineos also did well as corporates frontloaded supply ahead of anticipated shortages. We used this as an opportunity to take profits via a complete sale.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Artemis Funds (Lux) – Global High Yield Bond | 8.2% | 11.6% | 10.8% | -11.5% | 7.6% | 6.4% | n/a | n/a | n/a | n/a |
| ICE BofA Merrill Lynch Global High Yield Constrained USD Hedged Index | 8.5% | 9.2% | 13.0% | -11.4% | 3.0% | 6.5% | n/a | n/a | n/a | n/a |
Past performance is not a guide for the future. Source: Lipper Limited to 31 December 2025 for class I Acc USD. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor’s currency is different to that of the class.
We initiated several new positions during the quarter:
We also participated in the Keepmoat and Allwyn new issues, where we felt pricing was attractive and the underlying credit stories were compelling. Keepmoat represents another example of a bond being issued to refinance a prior release well ahead of maturity, a growing trend we continue to benefit from.
We exited our position in Coty following its re-rating to investment grade. With spreads having tightened significantly, we felt there was limited remaining upside. We also sold our holding in LSB Industries, where the bonds had moved close to their imminent call price, again limiting further return potential.
Elsewhere, we sold DeepOcean (subsea oil & gas maintenance) and Insulet (the manufacturer of diabetes delivery systems) and trimmed Clarivate (a provider of technical data to the medical and education industries).
We will refrain from second guessing what the outcome of the conflict in the Middle East will be. The world could look completely different come next week.
What we can talk about is the significant revaluation that has occurred in high-yield markets. High yield is an inherently high-income and low-duration asset class. As such, while market prices can (and do) move around on events and uncertainties, these moves create comparatively large movements in the measure of forward value – yields.
As duration shortens, yield becomes an ever more powerful predictor of forward total returns. The fund’s USD-hedged yield is 8.4% – squarely in the 8 to 9% range that, in the past, has tended to produce forward returns of more than 10% over the following 12 months.
We cannot predict what the next month or two will hold – but what we can do is gather up opportunities to deliver high single-digit yields to investors over a relatively near-term timeframe, while doing our best to minimise default risk. While we don’t know how this will affect month-to-month performance, we firmly believe it will result in superior long-term returns.
FOR PROFESSIONAL INVESTORS AND/OR QUALIFIED INVESTORS AND/OR FINANCIAL INTERMEDIARIES ONLY. NOT FOR USE WITH OR BY PRIVATE INVESTORS.
CAPITAL AT RISK. All financial investments involve taking risk and the value of your investment may go down as well as up. This means your investment is not guaranteed and you may not get back as much as you put in. Any income from the investment is also likely to vary and cannot be guaranteed.
This is a marketing communication. Before making any final investment decisions, and to understand the investment risks involved, refer to the fund prospectus (or in the case of investment trusts, Investor Disclosure Document and Articles of Association), available in English, and KIID/KID, available in English and in your local language depending on local country registration, available in the literature library.
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.